Burger R L, Mehlman C S, Allen R H
J Biol Chem. 1975 Oct 10;250(19):7700-6.
Transcobalamin I and transcobalamin III have been purified approximately 6,000,000- and 3,000,000-fold, respectively, from normal human plasma using a purification scheme consisting of immunoadsorption, dialysis against 7.5 M guanidine HCl to remove endogenous vitamin B12, and affinity chromatography on vitamin B12-Sepharose. The two proteins were separated from each other subsequently by chromatography on DEAE-cellulose. The vitamin B12-binding protein present in granulocytes obtained from normal subjects has been purified approximately 5000-fold using affinity chromatography on vitamin B12-Sepharose as the sole purification technique. The final preparations of all three proteins were homogeneous based on sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Transcobalamin I and transcobalamin III belong to the R-typed class of vitamin B12-binding proteins and are indistinguishable from each other, and from the human granulocyte, milk, and saliva R-type vitamin B12-binding proteins, when studied by immunodiffusion with rabbit anti-human milk vitamin B12-binding protein sera. The carbohydrate compositions, expressed as moles of carbohydrate per mole of vitamin B12, of transcobalamin I, transcobalamin III, and the normal granulocyte vitamin B12-binding protein, respectively, are: sialic acid, 18, 11, 11; fucose, 9, 20, 24; galactose, 41, 51, 46; mannose, 24, 22, 20; galactosamine, 2, 2, 2; and glucosamine, 46, 54, 46. The high sialic acid content of transcobalamin I appears to account for the fact that this protein elutes after transcobalamin III and the normal granulocyte vitamin B12-binding protein during chromatography on DEAE-cellulose. This observation provides support for the hypothesis that differences among the R-type vitamin B12-binding proteins are due to differences in carbohydrate content. The similarities in carbohydrate composition and other properties of transcobalamin III and the granulocyte vitamin B12-binding protein provide support for the hypothesis that human plasma transcobalamin III is derived from granulocytes. The differences observed between transcobalamin I and the normal granulocyte vitamin B12-binding protein suggest that transcobalamin I may not be derived from granulocytes.
运用包含免疫吸附、用7.5M盐酸胍透析以去除内源性维生素B12以及在维生素B12 - 琼脂糖上进行亲和层析的纯化方案,已分别从正常人血浆中纯化出钴胺素I和钴胺素III,纯化倍数约为600万倍和300万倍。随后通过DEAE - 纤维素层析将这两种蛋白质彼此分离。使用维生素B12 - 琼脂糖上的亲和层析作为唯一纯化技术,已将从正常受试者获得的粒细胞中存在的维生素B12结合蛋白纯化了约5000倍。基于十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳,所有三种蛋白质的最终制剂均为纯品。钴胺素I和钴胺素III属于R型维生素B12结合蛋白类别,彼此之间以及与人类粒细胞、乳汁和唾液中的R型维生素B12结合蛋白难以区分,当用兔抗人乳维生素B12结合蛋白血清进行免疫扩散研究时。钴胺素I、钴胺素III和正常粒细胞维生素B12结合蛋白的碳水化合物组成,分别以每摩尔维生素B12的碳水化合物摩尔数表示为:唾液酸,18、11、11;岩藻糖,9、20、24;半乳糖,41、51、46;甘露糖,24、22、20;半乳糖胺,2、2、2;以及葡糖胺,46、54、46。钴胺素I的高唾液酸含量似乎解释了这样一个事实,即在DEAE - 纤维素层析过程中,该蛋白质比钴胺素III和正常粒细胞维生素B12结合蛋白洗脱得晚。这一观察结果为R型维生素B12结合蛋白之间的差异是由于碳水化合物含量差异这一假说提供了支持。钴胺素III和粒细胞维生素B12结合蛋白在碳水化合物组成和其他性质方面的相似性为人类血浆钴胺素III源自粒细胞这一假说提供了支持。钴胺素I与正常粒细胞维生素B12结合蛋白之间观察到的差异表明,钴胺素I可能并非源自粒细胞。